Iguana Healthcare Management, LLC - Q1 2015 holdings

$238 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .

 Value Shares↓ Weighting
ESPR  ESPERION THERAPEUTICS INC NE$18,520,000
+129.0%
200,0000.0%7.79%
+99.3%
CELG  CELGENE CORP$12,681,000
+3.1%
110,0000.0%5.33%
-10.3%
SUPN  SUPERNUS PHARMACEUTICALS INC$6,045,000
+45.7%
500,0000.0%2.54%
+26.8%
HZNP  HORIZON PHARMA PLC$5,194,000
+101.5%
200,0000.0%2.18%
+75.4%
TRNX  TORNIER N V$3,933,000
+2.8%
150,0000.0%1.65%
-10.5%
CLDX  CELLDEX THERAPEUTICS INC NEW$2,787,000
+52.7%
100,0000.0%1.17%
+32.9%
SPNC  SPECTRANETICS CORP$1,738,000
+0.5%
50,0000.0%0.73%
-12.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2015-06-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOGEN INC17Q1 20187.5%
ULTRAGENYX PHARMACEUTICAL IN17Q1 20186.7%
MERCK & CO INC NEW16Q1 20185.4%
CELGENE CORP15Q4 20177.9%
AERIE PHARMACEUTICALS INC15Q4 20173.3%
GILEAD SCIENCES INC14Q1 20176.7%
ESPERION THERAPEUTICS INC NE14Q1 20187.8%
SUPERNUS PHARMACEUTICALS INC14Q4 20172.8%
DERMIRA INC14Q1 20182.7%
AMGEN INC13Q1 20176.5%

View Iguana Healthcare Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2018-05-15
13F-HR2018-02-14
13F-HR/A2017-11-16
13F-HR2017-11-14
13F-HR2017-08-14
13F-HR2017-05-15
13F-HR2017-02-14
13F-HR/A2016-11-17
13F-HR2016-11-14
13F-HR/A2016-11-04

View Iguana Healthcare Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Iguana Healthcare Management, LLC's holdings